FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

1078691000202108: Product containing precisely tipiracil (as tipiracil hydrochloride) 6.14 milligram and trifluridine 15 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Sep 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
11789771000202119 Product containing precisely tipiracil (as tipiracil hydrochloride) 6.14 milligram and trifluridine 15 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
11795571000202114 Tipiracil (as tipiracil hydrochloride) 6.14 mg and trifluridine 15 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely tipiracil (as tipiracil hydrochloride) 6.14 milligram and trifluridine 15 milligram/1 each conventional release oral tablet (clinical drug) Is a Tipiracil and trifluridine only product in oral dose form true Inferred relationship Some
Product containing precisely tipiracil (as tipiracil hydrochloride) 6.14 milligram and trifluridine 15 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form Oral tablet true Inferred relationship Some
Product containing precisely tipiracil (as tipiracil hydrochloride) 6.14 milligram and trifluridine 15 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Product containing precisely tipiracil (as tipiracil hydrochloride) 6.14 milligram and trifluridine 15 milligram/1 each conventional release oral tablet (clinical drug) Plays role Antineoplastic therapeutic role true Inferred relationship Some
Product containing precisely tipiracil (as tipiracil hydrochloride) 6.14 milligram and trifluridine 15 milligram/1 each conventional release oral tablet (clinical drug) Plays role Antiviral therapeutic role true Inferred relationship Some
Product containing precisely tipiracil (as tipiracil hydrochloride) 6.14 milligram and trifluridine 15 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Trifluridine (substance) true Inferred relationship Some 1
Product containing precisely tipiracil (as tipiracil hydrochloride) 6.14 milligram and trifluridine 15 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Trifluridine (substance) true Inferred relationship Some 1
Product containing precisely tipiracil (as tipiracil hydrochloride) 6.14 milligram and trifluridine 15 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit mg true Inferred relationship Some 1
Product containing precisely tipiracil (as tipiracil hydrochloride) 6.14 milligram and trifluridine 15 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 1
Product containing precisely tipiracil (as tipiracil hydrochloride) 6.14 milligram and trifluridine 15 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Tipiracil hydrochloride (substance) true Inferred relationship Some 2
Product containing precisely tipiracil (as tipiracil hydrochloride) 6.14 milligram and trifluridine 15 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Tipiracil (substance) true Inferred relationship Some 2
Product containing precisely tipiracil (as tipiracil hydrochloride) 6.14 milligram and trifluridine 15 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit mg true Inferred relationship Some 2
Product containing precisely tipiracil (as tipiracil hydrochloride) 6.14 milligram and trifluridine 15 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 2

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start